Screening of patients with tuberculosis for diabetes mellitus in ChinaDepistage du diabete sucre chez les patients atteints de tuberculose en ChineDiagnostico de Diabetes Mellitus en pacientes con Tuberculosis en China

• Published in: Tropical medicine & international health 2012-10, Vol.17 (10), p.1294-1301
• Main Authors: Li, Liang, Lin, Yan, Mi, Fengling, Tan, Shouyong, Liang, Bing, Guo, Chaojun, Shi, Lian, Liu, Li, Gong, Fang, Li, Yuanyuan, Chi, Jingyu, Zachariah, Rony, Kapur, Anil, Lonnroth, Knut, Harries, Anthony D
• Format: Article
• Language: English
• Subjects: Mycobacterium
• ISSN: 1360-2276; 1365-3156
• DOI: 10.1111/j.1365-3156.2012.03068.x

Objective There is a high burden of both diabetes (DM) and tuberculosis (TB) in China, and this study aimed to assess feasibility and results of screening patients with TB for DM within the routine healthcare setting of six health facilities. Method Agreement on how to screen, monitor and record was reached in May 2011 at a stakeholders' meeting, and training was carried out for staff in the six facilities in July 2011. Implementation started in September 2011, and we report on 7months of activities up to 31 March 2012. Results There were 8886 registered patients with TB. They were first asked whether they had DM. If the answer was no, they were screened with a random blood glucose (RBG) followed by fasting blood glucose (FBG) in those with RBG greater than or equal to 6.1mm (one facility) or with an initial FBG (five facilities). Those with FBG greater than or equal to 7.0mm were referred to DM clinics for diagnostic confirmation with a second FBG. Altogether, 1090 (12.4%) patients with DM were identified, of whom 863 (9.7%) had a known diagnosis of DM. Of 8023 patients who needed screening for DM, 7947 (99%) were screened. This resulted in a new diagnosis of DM in 227 patients (2.9% of screened patients), and of these, 226 were enrolled to DM care. In addition, 575 (7.8%) persons had impaired fasting glucose (FBG 6.1 to